Search

PerkinElmer Inc

Slēgts

SektorsVeselības aprūpe

0

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

Max

Galvenie mērījumi

By Trading Economics

Ienākumi

11M

52M

Pārdošana

19M

730M

P/E

Sektora vidējais

55.248

57.002

EPS

1.41

Dividenžu ienesīgums

0.12

Peļņas marža

7.102

Darbinieki

11,000

EBITDA

8.8M

189M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

-2.01% downside

Dividendes

By Acuity

Dividenžu ienesīgums

Sektora vidējais

0.12%

2.22%

Nākamie ieņēmumi

2026. g. 26. okt.

Nākamais dividenžu datums

2026. g. 13. nov.

Nākamais Ex dividenžu datums

2026. g. 23. okt.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

89M

13B

Iepriekšējā atvēršanas cena

0

Iepriekšējā slēgšanas cena

0

Ziņu noskaņojums

By Acuity

14%

86%

26 / 340 Rangs Healthcare

PerkinElmer Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 13. aug. 19:46 UTC

News

Revvity shares are lower despite Q2 revenue and non-GAAP earnings growth. Analysts raised concerns about segment dynamics and competitive challenges following the earnings report.

2026. g. 12. aug. 19:46 UTC

Revvity Inc shares are higher today, supported by positive market sentiment following a favorable inflation report and strong quarterly results from technology companies.

2026. g. 11. aug. 20:13 UTC

Revvity Inc. shares are trading roughly flat after-market hours, with market sentiment influenced by expectations for the upcoming Consumer Price Index report.

2026. g. 10. aug. 22:01 UTC

Revvity Inc shares are trading higher in after-market hours, following broader market dynamics and reduced expectations for Federal Reserve rate hikes.

2026. g. 7. aug. 19:46 UTC

Revvity Inc shares are higher today, maintaining a position above the 20-day moving average and near the upper end of their one-month range.

2026. g. 6. aug. 20:51 UTC

Revvity Inc shares are lower in after-market hours, with no specific news identified. The asset remains above its 20-day moving average.

2026. g. 5. aug. 19:52 UTC

News

Revvity Inc shares are higher as Evercore ISI raises its price target to $126, supported by strong quarterly performance and increased guidance.

2026. g. 4. aug. 19:51 UTC

Social Media
News

Revvity Inc shares are lower following second-quarter results that showed organic revenue growth of 3% and a slight miss on overall revenue estimates.

2026. g. 3. aug. 19:44 UTC

News

Revvity Inc shares are higher ahead of tomorrow's earnings report, with analysts projecting a 3.9% revenue growth year-on-year, recovering from last year's decline.

2026. g. 31. jūl. 19:16 UTC

Revvity Inc shares are lower today amid broader market declines, influenced by rising yields and inflation concerns following a significant increase in crude oil prices.

2026. g. 29. jūl. 20:08 UTC

Revvity Inc shares are higher today, reflecting a steady upward trend amid rising oil prices and broader market influences. The stock is near its one-month range high.

2026. g. 28. jūl. 20:03 UTC

Revvity Inc shares are higher during Tuesday's session, continuing their advance since Monday's close, despite broader market weakness in Asian indices.

2026. g. 27. jūl. 21:02 UTC

Revvity Inc shares are lower in after-market hours, continuing a downward trend with three consecutive daily declines. No specific news was identified for the movement.

2026. g. 22. jūl. 18:51 UTC

Revvity Inc shares are higher since Tuesday's close amid broader market gains, influenced by rising crude oil prices from geopolitical tensions involving the U.S. and Iran.

2026. g. 21. jūl. 20:02 UTC

Revvity Inc shares are higher, supported by renewed interest in AI stocks and anticipation of earnings from major companies like Alphabet and Tesla.

2026. g. 20. jūl. 19:21 UTC

News

Revvity Inc. published its 2026 Impact Report, disclosing Scope 3 emissions. Shares are lower amid broader industry challenges and a cautious analyst outlook.

Salīdzinājums

Cenas izmaiņa

PerkinElmer Inc Prognoze

Cenas mērķis

By TipRanks

-2.01% uz leju

Prognoze 12 mēnešiem

Vidējais 115.14 USD  -2.01%

Augstākais 130 USD

Zemākais 105 USD

Pamatojoties uz 9 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi PerkinElmer Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

9 ratings

3

Pirkt

6

Turēt

0

Pārdot

Noskaņojums

By Acuity

26 / 340 Rangs Veselības aprūpe

Ziņu noskaņojums

Ļoti spēcīga liecība "buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Virs vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par PerkinElmer Inc

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
help-icon Live chat